Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining botulinum toxin type A with Minoxidil significantly improves hair growth and patient satisfaction in male hair loss.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Genetically modified umbilical cord blood cells improved skin wound healing in rats.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Afatinib often causes skin problems that need proactive management.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Pulsed electric field treatment may help shrink untreated liver tumors.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Targeting PTEN can improve healing in venous leg ulcers.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.